Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer

Xue-bin Yan, Tuo-chao Peng, Dong Huang Department of Anesthesiologist, The Third Xiangya Hospital of Central South University, Changsha, Hunan Province, People’s Republic of China Abstract: Endothelin-1 (ET-1) may be involved in driving pain in patients with advanced cancer. However, a f...

Full description

Bibliographic Details
Main Authors: Yan XB, Peng TC, Huang D
Format: Article
Language:English
Published: Dove Medical Press 2015-12-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/correlations-between-plasma-endothelin-1-levels-and-breakthrough-pain--peer-reviewed-article-OTT
id doaj-029cce94f60a4ad8ac0d0a2d3cd5f665
record_format Article
spelling doaj-029cce94f60a4ad8ac0d0a2d3cd5f6652020-11-25T00:57:24ZengDove Medical PressOncoTargets and Therapy1178-69302015-12-012015Issue 13703370624905Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancerYan XBPeng TCHuang DXue-bin Yan, Tuo-chao Peng, Dong Huang Department of Anesthesiologist, The Third Xiangya Hospital of Central South University, Changsha, Hunan Province, People’s Republic of China Abstract: Endothelin-1 (ET-1) may be involved in driving pain in patients with advanced cancer. However, a few studies focus on the role of ET-1 in breakthrough pain (BP). The aim of this pivotal study was to explore the correlation between the plasma (ET-1) level and BP intensity. A total of 40 patients were enrolled in the study, and they were divided into two groups: BP group and non-BP group. Moreover, 20 healthy adults were used as the normal control group. Pain intensity was measured using visual analog scale (VAS) scores of 1–10. Plasma ET-1 levels were detected by an ET radioimmunoassay kit. Subsequently, the correlation of ET-1 level with the VAS score and cancer types was analyzed by Pearson’s correlation coefficient. The plasma ET-1 level in the BP group (35.31±8.02 pg/mL) was higher than that in the non-BP group (29.51±6.78 pg/mL) and the normal control group (24.77±10.10 pg/mL, P<0.05). In addition, the VAS score in the BP group (7.45±0.82) was higher than that in the non-BP group (2.80±1.23, P<0.05). The plasma ET-1 level was positively correlated with the VAS score of the BP group (Pearson’s r=0.42). There was no significant correlation between the plasma ET-1 level and VAS score of the non-BP group (Pearson’s r=–0.22) or/and cancer types (P>0.05). The elevated plasma ET-1 levels were positively related to BP, and targeting ET-1 may provide a novel pain-reducing therapeutic treatment in BP. Keywords: visual analog scale, correlation, cancer types, background painhttps://www.dovepress.com/correlations-between-plasma-endothelin-1-levels-and-breakthrough-pain--peer-reviewed-article-OTTvisual analog scalecorrelationcancer typesbackground pain
collection DOAJ
language English
format Article
sources DOAJ
author Yan XB
Peng TC
Huang D
spellingShingle Yan XB
Peng TC
Huang D
Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer
OncoTargets and Therapy
visual analog scale
correlation
cancer types
background pain
author_facet Yan XB
Peng TC
Huang D
author_sort Yan XB
title Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer
title_short Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer
title_full Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer
title_fullStr Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer
title_full_unstemmed Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer
title_sort correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2015-12-01
description Xue-bin Yan, Tuo-chao Peng, Dong Huang Department of Anesthesiologist, The Third Xiangya Hospital of Central South University, Changsha, Hunan Province, People’s Republic of China Abstract: Endothelin-1 (ET-1) may be involved in driving pain in patients with advanced cancer. However, a few studies focus on the role of ET-1 in breakthrough pain (BP). The aim of this pivotal study was to explore the correlation between the plasma (ET-1) level and BP intensity. A total of 40 patients were enrolled in the study, and they were divided into two groups: BP group and non-BP group. Moreover, 20 healthy adults were used as the normal control group. Pain intensity was measured using visual analog scale (VAS) scores of 1–10. Plasma ET-1 levels were detected by an ET radioimmunoassay kit. Subsequently, the correlation of ET-1 level with the VAS score and cancer types was analyzed by Pearson’s correlation coefficient. The plasma ET-1 level in the BP group (35.31±8.02 pg/mL) was higher than that in the non-BP group (29.51±6.78 pg/mL) and the normal control group (24.77±10.10 pg/mL, P<0.05). In addition, the VAS score in the BP group (7.45±0.82) was higher than that in the non-BP group (2.80±1.23, P<0.05). The plasma ET-1 level was positively correlated with the VAS score of the BP group (Pearson’s r=0.42). There was no significant correlation between the plasma ET-1 level and VAS score of the non-BP group (Pearson’s r=–0.22) or/and cancer types (P>0.05). The elevated plasma ET-1 levels were positively related to BP, and targeting ET-1 may provide a novel pain-reducing therapeutic treatment in BP. Keywords: visual analog scale, correlation, cancer types, background pain
topic visual analog scale
correlation
cancer types
background pain
url https://www.dovepress.com/correlations-between-plasma-endothelin-1-levels-and-breakthrough-pain--peer-reviewed-article-OTT
work_keys_str_mv AT yanxb correlationsbetweenplasmaendothelin1levelsandbreakthroughpaininpatientswithcancer
AT pengtc correlationsbetweenplasmaendothelin1levelsandbreakthroughpaininpatientswithcancer
AT huangd correlationsbetweenplasmaendothelin1levelsandbreakthroughpaininpatientswithcancer
_version_ 1725224403773423616